StockData
Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc (TNDM) stock

TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3024% below fair value
$18.48−1.59 (-7.92%)

Close on Nov 16, 2026Market cap $1.29BP/E –Yield –

Tandem Diabetes Care Inc grew revenue 4.0% to $1.04B over the twelve months to Jun 30, 2026. Free cash flow was -$26.62M. At the latest close the market valued the company at $1.29B.

Revenue
$1.04B
+4.0% vs. a year earlier
Operating income
-$45.80M
TTM Q2 2026
Free cash flow
-$26.62M
TTM Q2 2026
EPS, diluted
-$0.93
TTM Q2 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$1.29B
P/E ratio
–
Price to sales
1.23
Price to book
9.86
Dividend yield
–
Free cash flow yield
-2.07%

Fundamentals

Revenue
$1.04B
Net income
-$63.32M
EPS, diluted
-$0.93
Free cash flow
-$26.62M
Book value per share
$1.89
Diluted shares
69M

Trading

Next earnings
Feb 18, 2027 (estimated, during market hours)
Previous close
$20.07
Open
$19.77
Day's range
$18.45 – $20.15
Volume
2,668,313
Average volume (20 days)
2,803,129
Index membership
S&P SmallCap 600 (since May 2023), Russell 2000 (since Sep 2024), Russell 3000
52-week range
$12.26 – $29.65
RSI (14 days)
51.8
Volatility (1 year)
76.0%
Relative volume
1.22×

On 1 of our idea list: Most shorted (a warning list)

Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2013, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 16, 2026. The S&P 500 is measured by the SPY fund.

PeriodTNDMS&P 500DifferenceTNDM per yearS&P 500 per year
1 month+13.8%-3.1%+16.8 pts
3 months-18.7%-4.5%−14.2 pts
Year to date-15.9%+9.4%−25.3 pts
1 year-0.7%+11.3%−12.0 pts
3 years+0.4%+70.4%−70.0 pts+0.1%+19.4%
5 years-87.0%+68.6%−155.6 pts-33.5%+11.0%
10 years-7.6%+297.7%−305.3 pts-0.8%+14.8%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$1.04B+4.0% YoY

Gross profit

$583.32M+10.8% YoY

Operating income

-$45.80M

Net income

-$63.32M

EPS, diluted

-$0.93

Free cash flow

-$26.62M
Reported periodTrailing twelve months

Press releases

Releases Tandem Diabetes Care filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Tandem Diabetes Care

Surgical & Medical Instruments & Apparatus

Tandem Diabetes Care, Inc. develops, manufactures, and sells medical devices and digital tools for diabetes management. The company primarily produces durable insulin pump systems, notably the t:slim X2 and Tandem Mobi, which incorporate its Control-IQ+ automated insulin delivery technology. It also provides disposable supplies, such as insulin cartridges and infusion sets, along with software applications including the Tandem Source data management platform and the Sugarmate mobile app. These products serve individuals with insulin-dependent diabetes, including people with type 1 diabetes and individuals with type 2 diabetes requiring intensive insulin therapy.

Company profile, executives and history

Tandem Diabetes Care stock: common questions

What is Tandem Diabetes Care's stock price?

TNDM closed at $18.48 on Nov 16, 2026, down 7.92% on the day. Over the past 52 weeks it traded between $12.26 and $29.65.

What is Tandem Diabetes Care's market cap?

Tandem Diabetes Care was worth $1.29B at the close on Nov 16, 2026: the share price times the diluted shares outstanding.

What is TNDM's P/E ratio?

Tandem Diabetes Care lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.93), so it has no meaningful P/E ratio.

How much revenue does Tandem Diabetes Care make?

Tandem Diabetes Care reported revenue of $1.04B for the twelve months to Jun 30, 2026, up 4.0% from a year earlier.

Does Tandem Diabetes Care pay a dividend?

No. Tandem Diabetes Care has not paid a cash dividend over the last twelve months.

When does Tandem Diabetes Care report earnings next?

Tandem Diabetes Care is expected to report Q4 FY2026 results on Feb 18, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.

How has TNDM stock performed over the past year?

Including dividends, TNDM returned -0.7% over the past year, against +11.3% for the S&P 500.

How many TNDM shares are sold short?

16M shares were sold short at the latest FINRA report, 23.52% of the float, or 7.6 days of average trading volume.

Who are Tandem Diabetes Care's competitors?

Companies most similar to Tandem Diabetes Care by business, industry and size include MMED, PODD, EMBC, ICUI, DXCM.

See a number that looks wrong?